Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
383
-
Total 13F shares, excl. options
-
48.6M
-
Shares change
-
-842K
-
Total reported value, excl. options
-
$5.73B
-
Value change
-
-$90.5M
-
Put/Call ratio
-
1.08
-
Number of buys
-
171
-
Number of sells
-
-190
-
Price
-
$118.08
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2016
445 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q3 2016.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 383 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.6M shares
.
Largest 10 shareholders include SCOPIA CAPITAL MANAGEMENT LP (4.09M shares), FMR LLC (4.03M shares), VANGUARD GROUP INC (3.59M shares), BlackRock Fund Advisors (2.27M shares), AJO, LP (2.09M shares), STATE STREET CORP (1.97M shares), Palo Alto Investors, LLC (1.76M shares), AQR CAPITAL MANAGEMENT LLC (1.58M shares), BlackRock Institutional Trust Company, N.A. (1.4M shares), and ACADIAN ASSET MANAGEMENT LLC (1.27M shares).
This table shows the top 383 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.